ceramide synthase 1
| GO Term | Evidence Code | PMID |
|---|---|---|
| sphingolipid metabolic process |
|
|
| brain development |
|
|
| negative regulation of cardiac muscle hypertrophy |
|
|
| sphingolipid biosynthetic process |
|
|
| sphingolipid biosynthetic process |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| endoplasmic reticulum |
|
|
| endoplasmic reticulum |
|
|
| endoplasmic reticulum |
|
|
| endoplasmic reticulum membrane |
|
|
| endoplasmic reticulum membrane |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| N-acyltransferase activity |
|
|
| sphingosine N-acyltransferase activity |
|
|
| sphingosine N-acyltransferase activity |
|
|
| sphingosine N-acyltransferase activity |
|
|
| sphingosine N-acyltransferase activity |
|
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0111451 | progressive myoclonus epilepsy 8 |
| HPO ID | HPO Term |
|---|---|
| HP:0000007 | Autosomal recessive inheritance |
| HP:0000639 | Nystagmus |
| HP:0000726 | Dementia |
| HP:0000750 | Delayed speech and language development |
| HP:0001249 | Intellectual disability |
| HP:0001260 | Dysarthria |
| HP:0001263 | Global developmental delay |
| HP:0001266 | Choreoathetosis |
| HP:0001272 | Cerebellar atrophy |
| HP:0001288 | Gait disturbance |
| Disease ID | Disease Name |
|---|---|
| OMIM:616230 |
|
| Species | Gene ID | Alliance of Genome Resources |
|---|---|---|
| 853861 | SGD:S000001491 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026